| abstract |
FIELD: medicine. SUBSTANCE: innovation deals with hemostatic sponges based either upon collagen and activator or proactivator of blood clotting, being steadily distributed in it, which could be dried and contain, at least, 2% water, preferably within 2-25%, more preferably within 10-20% and, also, with the method to obtain such a sponge. The latter is of higher plasticity and mechanical stability. It could, additionally, contain pharmacological active substances. EFFECT: higher efficiency of application. 21 cl, 4 ex |